Bio-Techne Corp. buy Citigroup Inc.
Start price
04.02.26
/
50%
€58.50
Target price
04.02.27
-
Performance (%)
-23.97%
Price
18.03.26
€44.40
Summary
This prediction is currently active. The prediction for Bio-Techne Corp. disappoints with a performance of -23.97%. Dividends of €0.080 are taken into consideration when calculating the performance. This prediction currently runs until 04.02.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Techne Corp. | -0.448% | -0.448% |
| iShares Core DAX® | -4.932% | -11.977% |
| iShares Nasdaq 100 | -2.634% | -2.218% |
| iShares Nikkei 225® | -4.733% | -10.900% |
| iShares S&P 500 | -2.544% | -3.540% |
Comments by Citigroup_Inc_ for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for TECH provided by MarketBeat